ICU导管相关感染患者干预前后的费用分析

Medical cost of intensive care unit patients with catheterassociated infection before and after intervention

摘要:

目的比较目标性干预前后重症监护室（ICU）导管相关感染患者医疗费用有无差异。方法采用回顾性调查方法，调查2010年（干预前组）、2013年（干预后组）某院ICU患者导管相关感染情况，比较两组患者的住院费用在干预前后的差异。结果干预后ICU导管相关感染患者发病率和病死率均明显下降，医院感染发病率由2010年的13.47%下降至2013年4.41%；病死率由2010年的10.36%下降至2013年的2.2%。实施目标性干预前后患者住院总费用、血费以及特殊材料费用比较，差异均有统计学意义（均P<0.05）；各感染指标相关费用比较中降钙素原检测和抗菌药物使用费用经统计学分析，差异均有统计学意义（均P<0.05）。结论干预后ICU患者发生导管相关医院感染医疗费用有下降。

Abstract:

ObjectiveTo compare whether there is a difference in medical cost of intensive care unit(ICU) patients with catheterassociated infection (CAI) between before and after targeted intervention. MethodsCAI in ICU patients in 2010(preintervention group) and 2013 (postintervention group) were investigated by retrospective survey, hospitalization cost of two groups of patients before and after intervention was compared.  ResultsThe morbidity and mortality in patients with CAI  both decreased significantly after intervention, morbidity of healthcareassociated infection(HAI) decreased from 13.47% in 2010 to 4.41% in 2013, mortality decreased from 10.36% in 2010 to 2.2% in 2103. Total hospitalization cost, blood transfusion cost, and cost of special material before and after the implementation of targeted intervention all significantly different (all P<0.05), the difference of procalcitonin and antimicrobial agents cost were also significant(all P<0.05). ConclusionMedical cost in ICU patients with CAI decreased after intervention.